NCT03073928

Brief Summary

One hundred and twenty patients will be randomized to Interscalene block or Paracoracoid Subscapularis plane block. The study will evaluate the efficacy and duration of blocks in the 2 groups with regards to postoperative analgesia and degree of respiratory depression.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Jun 2017

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 11, 2016

Completed
4 months until next milestone

First Posted

Study publicly available on registry

March 8, 2017

Completed
3 months until next milestone

Study Start

First participant enrolled

June 15, 2017

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

August 28, 2017

Status Verified

June 1, 2017

Enrollment Period

9 months

First QC Date

November 11, 2016

Last Update Submit

August 25, 2017

Conditions

Keywords

Nerve blockDiaphragm function

Outcome Measures

Primary Outcomes (1)

  • Duration of analgesia

    Duration in hours from end of injection to patient reported pain NRS score of more than 6/10

    Pain NRS measured every 120 minutes until score of 6/10 is obtained (up to 24 hours).

Secondary Outcomes (1)

  • Measurement of diaphragm thickening pre and post block

    3 measurements - pre block, 20 minutes post block & 1 hour post surgery

Other Outcomes (1)

  • Measurement of Forced Expiratory Volume in 1 second (FEV1)

    3 measurements - pre block, 20 minutes post block & 1 hour post surgery

Study Arms (2)

Interscalene Block

ACTIVE COMPARATOR

Receives interscalene block with 15mL of ropivacaine 0.5% at the level of C6. A total of 15mL will be injected with repeated aspirations to rule out intravascular placement of the needle tip. Once this is done, the needle tip will be moved to the lateral edge of sternocleidomastoid muscle and additional 3mL of 0.5% ropivacaine will be injected between the deep fascia of the sternocleidomastoid and deep investing fascia of the neck (superficial cervical plexus block SCP). We will administer injection of saline similar to experimental group to blind the patient

Procedure: Interscalene BlockDrug: Ropivacaine

Paracoracoid SPB

EXPERIMENTAL

Receives paracoracoid subscapularis plane block with the ultrasound. Using a 50mm 22G block needle 15ml of 0.5% Ropivacaine will be deposited anterior to the fascia of subscapularis muscle after eliciting a motor response with 0.6mA current delivered through the needle. Following this, superficial cervical plexus block will be done using 3mL of 0.5% ropivacaine similar to group 1.

Procedure: Paracoracoid SPBDrug: Ropivacaine

Interventions

Regional Anesthesia procedure in the neck

Interscalene Block

Regional anesthesia procedure under the collar bone

Paracoracoid SPB

Amide local anesthetic Ropivacaine will be used in same concentration (milligrams) in both active comparator and experimental group

Interscalene BlockParacoracoid SPB

Eligibility Criteria

Age16 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Male and females of 16-85years of age, scheduled to undergo arthroscopic shoulder surgery.
  • Elective shoulder surgery undergoing general anesthesia in combination with regional blockade.
  • ASA Class I,II and III
  • Able to give informed consent
  • Able to cooperate with study process
  • Availability of home telephone

You may not qualify if:

  • ASA 4
  • Refusal to have regional block
  • Lack of informed consent.
  • Language or reading barrier
  • Allergy to any of the drugs used in the study.
  • Patients with associated significant cardiac and respiratory disease.
  • Patients with pre-existing major organ dysfunction such as hepatic and renal failure.
  • Patients with coexisting hematological disorder or with deranged coagulation parameters.
  • Significant psychiatric illnesses. (Schizophrenia or bipolar disorders, uncontrolled anxiety or depression)
  • Narcotic dependency (Chronic opioid use of greater than 15 mg oral morphine equivalents daily)
  • Peripheral neuropathy
  • Pregnancy
  • Emergency surgery

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

London Health Sciences Centre, St. Joseph's Heath Care

London, Ontario, N6A 5A5, Canada

RECRUITING

Related Publications (1)

  • Sondekoppam RV, Lopera-Velasquez LM, Naik L, Ganapathy S. Subscapularis and sub-omohyoid plane blocks: an alternative to peripheral nerve blocks for shoulder analgesia. Br J Anaesth. 2016 Dec;117(6):831-832. doi: 10.1093/bja/aew370. No abstract available.

    PMID: 27956687BACKGROUND

MeSH Terms

Conditions

Rotator Cuff Injuries

Interventions

Ropivacaine

Condition Hierarchy (Ancestors)

RuptureWounds and InjuriesShoulder InjuriesTendon Injuries

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAmines

Study Officials

  • Sugantha Ganapathy, MD, FRCPC

    Western University, Canada

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sugantha Ganapathy, MD, FRCPC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 11, 2016

First Posted

March 8, 2017

Study Start

June 15, 2017

Primary Completion

March 1, 2018

Study Completion

December 1, 2018

Last Updated

August 28, 2017

Record last verified: 2017-06

Data Sharing

IPD Sharing
Will not share

Locations